Giancarlo Zatti

Learn More
The authors review 26 patients who underwent either "in situ" extracapsular epiphysiodesis or intracapsular reduction followed by epiphysiodesis for slipped capital femoral epiphysis (SCFE). A total(More)
BACKGROUND Sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce glucose levels, body weight, and blood pressure, possibly resulting in cardiovascular protection. In phase III trials, SGLT2i(More)